Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Phase IV Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive Patients
Conditions
Interventions
Fimasartan
Atenolol
Locations
4
South Korea
Hallym University Medical Center
Anyang, South Korea
Gachon University Gil Hospital
Incheon, South Korea
Severance Hospital
Seoul, South Korea
Kangnam Severance Hospital
Seoul, South Korea
Start Date
October 1, 2012
Primary Completion Date
June 1, 2016
Last Updated
September 23, 2016
NCT02417740
NCT07073820
NCT07480265
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Boryung Pharmaceutical Co., Ltd
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions